These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16025234)

  • 21. Ximelagatran or warfarin in atrial fibrillation?
    Epstein EF
    Lancet; 2004 Feb; 363(9410):736; author reply 736. PubMed ID: 15001338
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
    Halperin JL
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ximelagatran or warfarin in atrial fibrillation?
    MacAllister R; Hingorani AD; Casas JP
    Lancet; 2004 Feb; 363(9410):735-6; author reply 736. PubMed ID: 15001337
    [No Abstract]   [Full Text] [Related]  

  • 24. Ximelagatran or warfarin in atrial fibrillation?
    Eikelboom J; Hankey G
    Lancet; 2004 Feb; 363(9410):734; author reply 734, 736. PubMed ID: 15001334
    [No Abstract]   [Full Text] [Related]  

  • 25. Ximelagatran or warfarin in atrial fibrillation?
    Stöllberger C; Finsterer J
    Lancet; 2004 Feb; 363(9410):734-5; author reply 736. PubMed ID: 15001336
    [No Abstract]   [Full Text] [Related]  

  • 26. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
    Halperin JL
    J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New possibilities in anticoagulant management of atrial fibrillation.
    Waldo AL
    Rev Cardiovasc Med; 2004; 5 Suppl 5():S30-8. PubMed ID: 15619613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ximelagatran: a new oral anticoagulant.
    Hrebickova L; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ximelagatran for stroke prevention in atrial fibrillation.
    Boos CJ; Lip GY
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):551-63. PubMed ID: 16076267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Will this be the end of the anticoagulation clinic for patients with atrial fibrillation?
    Mitchell AR
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):405-8. PubMed ID: 16248832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
    Scardi S; Giansante C
    Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
    Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ximelagatran in prevention of cardiovascular events.
    Molckovsky D; Boucher M
    Issues Emerg Health Technol; 2004 Nov; (62):1-4. PubMed ID: 15565751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?
    Hankey GJ; Klijn CJ; Eikelboom JW
    Stroke; 2004 Feb; 35(2):389-91. PubMed ID: 14757889
    [No Abstract]   [Full Text] [Related]  

  • 35. Stroke prevention in atrial fibrillation: anticoagulants and antithrombotics.
    Ezekowitz MD
    Am Heart Hosp J; 2004; 2(4 Suppl 1):31-5. PubMed ID: 15539973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
    Gomberg-Maitland M; Wenger NK; Feyzi J; Lengyel M; Volgman AS; Petersen P; Frison L; Halperin JL
    Eur Heart J; 2006 Aug; 27(16):1947-53. PubMed ID: 16774980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
    Lip GY; Lane DA
    Am J Med; 2010 Sep; 123(9):785-9. PubMed ID: 20655037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation for atrial fibrillation in the elderly.
    Halperin JL
    Am J Geriatr Cardiol; 2005; 14(2):81-6. PubMed ID: 15785149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.
    Cleland JG; Shelton R; Nikitin N; Ford S; Frison L; Grind M
    Eur J Heart Fail; 2007; 9(6-7):730-9. PubMed ID: 17360232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.